P53 nuclear overexpression and disease progression in ta-bladder carcinoma.

Abstract

This study investigates the prevalence and clinical relevance of nuclear overexpression of the p53 protein, as detected by antibody PAb1801, in 54 patients with pathologically confirmed Ta bladder carcinomas obtained by transurethral resection at Memorial Sloan-Kettering Cancer Center between 1972 and 1980. No patient received any prior adjuvant therapy… (More)

Topics

Cite this paper

@article{Sarkis1993P53NO, title={P53 nuclear overexpression and disease progression in ta-bladder carcinoma.}, author={Alvaro Sadek Sarkis and Z Zhang and C Cordoncardo and Jonathan Melamed and Guido Dalbagni and Joel Sheinfeld and William R. Fair and Harry W. Herr and Victor Reuter}, journal={International journal of oncology}, year={1993}, volume={3 2}, pages={355-60} }